Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Siemens Builds Toward Smarter Buildings with Enlighted Inc. Acquisition May 29, 2018 Siemens introduces Simatic MV550 optical reader March 25, 2019 Balluff introduces BTL7-T500 position measuring system April 12, 2018